A conserved human T cell population targets mycobacterial antigens presented by CD1b

I Van Rhijn; A Kasmar; A De Jong; S Gras; M Bhati; ME Doorenspleet; N De Vries; DI Godfrey; JD Altman; W De Jager; J Rossjohn; DB Moody

Journal article

A conserved human T cell population targets mycobacterial antigens presented by CD1b

I Van Rhijn, A Kasmar, A De Jong, S Gras, M Bhati, ME Doorenspleet, N De Vries, DI Godfrey, JD Altman, W De Jager, J Rossjohn, DB Moody

Nature Immunology | Published : 2013

DOI: 10.1038/ni.2630

Abstract

Human T cell antigen receptors (TCRs) pair in millions of combinations to create complex and unique T cell repertoires for each person. Through the use of tetramers to analyze TCRs reactive to the antigen-presenting molecule CD1b, we detected T cells with highly stereotyped TCR α-chains present among genetically unrelated patients with tuberculosis. The germline-encoded, mycolyl lipid-reactive (GEM) TCRs had an α-chain bearing the variable (V) region TRAV1-2 rearranged to the joining (J) region TRAJ9 with few nontemplated (N)-region additions. Analysis of TCRs by high-throughput sequencing, binding and crystallography showed linkage of TCRα sequence motifs to high-affinity recognition of ant..

View full abstract

University of Melbourne Researchers

Dale Godfrey Author

Jamie Rossjohn Author

Related Projects (3)

IMMUNE REGULATION EFFECTOR FUNCTION AND THERAPY

We seek to understand how white blood cells detect and destroy disease, and how molecules of the immune system punch holes in diseased cells..

IMMUNE REGULATION EFFECTOR FUNCTION AND THERAPY

We seek to understand how white blood cells detect and destroy disease, and how molecules of the immune system punch holes in diseased cells..

RESEARCH FELLOWSHIP

Professor Godfrey is an immunologist with a long standing history as a pioneer in the study of a specialised type of white blood cell, known..

Grants

Awarded by National Institute of Allergy and Infectious Diseases

Funding Acknowledgements

We thank the Tetramer Core Facility of the US National Institutes of Health for CD1b protein; M. Turner, C. Seshadri and the Shattuck Hospital for clinical collaboration; L. Tan for technical help; and the beamline staff at the Australian synchrotron for assistance with data collection. Supported by the US National Institute of Allergy and Infectious Diseases (AI04393, AR048632 to D. B. M., and K08 AI089858 to A. K.) the Burroughs Wellcome Fund, Nederlands Wetenschappelijk Onderzoek (Meervoud 836.08.001 to I. V. R.), the National Health and Medical Research Council (D. I. G. and J.R.) and the Australian Research Council (S.G.).